Weining “Ken” Zhen, M.D., professor of radiation oncology at UNMC, has been named an American Society for Radiation Oncology Fellow (FASTRO). The society is the world’s largest society for radiation oncology professionals.
Weining “Ken” Zhen, M.D. |
Dr. Zhen called his selection a tremendous honor.
“The honor really goes to all faculty of our department of radiation oncology and the excellent cancer program at UNMC,” he said.
Charles Enke, M.D., chair of the UNMC Department of Radiation Oncology, said he was proud of Dr. Zhen for being recognized by ASTRO.
“Dr. Zhen is an internationally recognized expert in head and neck oncology, although his clinical skills go well beyond a single disease site,” Dr. Enke said. “Ken has contributed significantly to the education of resident and practicing radiation oncologists, and he has worked with ASTRO and SANTRO (the Sino-American Network for Therapeutic Radiology and Oncology) to optimize the delivery of radiation therapy for patients in China. We are fortunate to have Ken at UNMC and Nebraska Medicine.”
Awarded annually since 2006, the ASTRO Fellows program recognizes individuals who have made significant contributions to radiation oncology through research, education, patient care and/or service to the field. Since its inception, the FASTRO designation has been awarded to just 327 of ASTRO’s more than 10,000 members worldwide; the 2018 class of Fellows comprises 35 individuals.
“Dr. Zhen joins an elite group of physicians and medical physicists who are recognized for their far-reaching contributions to the field of radiation oncology and their progress in advancing cancer research, education and patient care,” said Brian Kavanagh, M.D., chair of the ASTRO Board of Directors.
More information about the Fellows program is available via the ASTRO website, including the list of 2018 Fellows, the complete list of ASTRO Fellows and information about the nomination and selection process.
Ken: Congratulations! Well deserved.
Congratulations Dr. Zhen on your ASTRO Fellowship! There is no doubt that you excel in this field of education of residents, and treatment of head and neck cancers. My husband is proof of that, because he is alive and doing well. Thank you for your contributions, research, education, but also your patient care. Donna & Mike Mahlendorf